BRAZIL-TNT
Phase 3 Unknown
150 enrolled
Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
Phase 2 Unknown
70 enrolled
Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer
Phase 2 Unknown
17 enrolled
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
Phase 2 Unknown
30 enrolled
FOTAC
Phase 2 Unknown
200 enrolled
A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
Phase 1/2 Unknown
160 enrolled
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Phase 2 Unknown
100 enrolled
Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer
Phase 3 Unknown
1,608 enrolled
FOWARC
Phase 2/3 Unknown
495 enrolled
RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).
Phase 2 Unknown
110 enrolled
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 3 Unknown
312 enrolled
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 3 Unknown
900 enrolled
Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Unknown
20 enrolled
Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer
Phase 3 Unknown
774 enrolled
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
Phase 3 Unknown
1,050 enrolled
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Phase 1 Unknown
Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
Phase 3 Unknown
336 enrolled
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
Phase 3 Unknown
340 enrolled
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2 Unknown
100 enrolled
Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
47 enrolled
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
Phase 2 Unknown
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 3 Unknown
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2/3 Unknown
600 enrolled
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
Phase 2 Unknown
35 enrolled
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
Phase 2 Unknown
206 enrolled
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 3 Unknown
109 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
Phase 2 Unknown
Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.
Phase 3 Unknown
1,200 enrolled